Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-May 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 79854701000001116 | Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 79854801000001113 | Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has VMP | Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has specific active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has specific active ingredient | Epinephrine bitartrate | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Epinephrine | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has basis of strength substance | Epinephrine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (Special Order) 1 ampoule | Is a | True | Lidocaine 100mg/10ml (1%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules 1 ampoule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR